Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Horizon Therapeutics Public Limited Company (HZNP)

96.3   -0.55 (-0.57%) 12-07 16:00
Open: 97.25 Pre. Close: 96.85
High: 98.2199 Low: 96.221
Volume: 2,323,725 Market Cap: 21,824(M)

Technical analysis

as of: 2022-12-07 4:23:01 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 122.85     One year: 143.48
Support: Support1: 81.8    Support2: 67.34
Resistance: Resistance1: 105.18    Resistance2: 122.85
Pivot: 86.08
Moving Average: MA(5): 99.47     MA(20): 83.4
MA(100): 70.23     MA(250): 85.53
MACD: MACD(12,26): 7.6     Signal(9): 6
Stochastic oscillator: %K(14,3): 75.2     %D(3): 82.9
RSI: RSI(14): 70.2
52-week: High: 117.48  Low: 57.84
Average Vol(K): 3-Month: 2,963 (K)  10-Days: 4,235 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HZNP ] has closed below upper band by 27.2%. Bollinger Bands are 238% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 98.43 - 99.02 99.02 - 99.46
Low: 94.81 - 95.59 95.59 - 96.18
Close: 95.28 - 96.43 96.43 - 97.28

Company Description

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.

Headline News

Mon, 05 Dec 2022
HZNP Stock Topples After J&J Pulls Out Of Bidding War | Investor's Business Daily - Investor's Business Daily

Wed, 30 Nov 2022
Healthcare Stocks Making Moves Wednesday: HZNP, CHEK, CGEN, AVDL, CNSP, ONCS, NBY, XFOR - InvestorsObserver

Wed, 30 Nov 2022
Hot Stocks: Chinese EV stocks jump; CRWD drops on earnings; S hits 52-week low; HZNP soars - Seeking Alpha

Wed, 30 Nov 2022
Noteworthy Wednesday Option Activity: NFLX, HZNP, CMG - Nasdaq

Wed, 30 Nov 2022
Health Care Sector Update for 11/30/2022: HZNP,SNY,JNJ,AMGN,CRL,ACER,CRL - Nasdaq

Wed, 30 Nov 2022
Horizon Therapeutics Draws Big Pharma Interest (NASDAQ:HZNP) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. 227 (M)
Shares Float 224 (M)
% Held by Insiders 1.1 (%)
% Held by Institutions 97 (%)
Shares Short 7,520 (K)
Shares Short P.Month 8,080 (K)

Stock Financials

EPS 2.45
EPS Est Next Qtl 0.23
EPS Est This Year 1.07
EPS Est Next Year 1.25
Book Value (p.s.) 22.01
Profit Margin (%) 15.5
Operating Margin (%) 21.2
Return on Assets (ttm) 5.5
Return on Equity (ttm) 12.1
Qtrly Rev. Growth -10.9
Gross Profit (p.s.) 10.85
Sales Per Share 16.32
EBITDA (p.s.) 3.57
Qtrly Earnings Growth -58
Operating Cash Flow 1,370 (M)
Levered Free Cash Flow 987 (M)

Stock Valuations

PE Ratio 39.3
PEG Ratio 1.3
Price to Book value 4.37
Price to Sales 5.89
Price to Cash Flow 15.92

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.